PMID- 32613273 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20200910 LR - 20200910 IS - 1436-5073 (Electronic) IS - 0026-3672 (Linking) VI - 187 IP - 7 DP - 2020 Jul 1 TI - Preparation of gold nanorod-incorporated monolith for solid phase extraction of polycyclic aromatic hydrocarbons. PG - 418 LID - 10.1007/s00604-020-04401-9 [doi] AB - An organic-inorganic hybrid monolithic column doped with gold nanorods (AuNRs) was prepared and evaluated for solid phase extraction (SPE) of polycyclic aromatic hydrocarbons (PAHs). Excellent dispersibility of AuNRs in binary green porogen system consisting of 1-hexyl-3-methylimidazolium tetrafluoroborate and deep eutectic solvents (DESs) was confirmed by energy dispersive spectrometry (EDS). The particle size of the resulting AuNRs (70-90 nm) was thoroughly examined by a transmission electron microscopy (TEM). The redox system including ammonium persulfate (APS) and tetramethylethylenediamine (TEMED) was used to initiate in situ polymerization at 4 degrees C to prepare the hybrid monolith. The mesoporous structure of the AuNR hybrid monoliths was confirmed by scanning electron microscopy (SEM) and nitrogen adsorption. With enrichment factors (EFs) of 150- to 292-fold, the developed method was successfully applied to the determination of 10 PAHs in wastewater samples. The recoveries at a spiked level were in the range 84.9 to 99.5% with limit of detections (LODs) and relative standard deviations (RSDs) ranging from 0.02 to 0.10 mug L(-1) and 1.5 to 4.2%, respectively. The correlation coefficients (R(2)) for the calibration function obtained were better 0.9991 for the target compounds. Compared to the AuNR-free monolith, the extraction efficiency of the AuNR-incorporated monolith is more than two times higher. The results indicated that the doping of AuNRs is an effective approach to obtain the hybrid monolithic column with good separation ability for PAHs. Graphical abstract. FAU - Zhang, Xue AU - Zhang X AD - Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, 300070, China. FAU - Shen, Yan-Feng AU - Shen YF AD - Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, 300070, China. FAU - Li, Xin-Xin AU - Li XX AD - Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, 300070, China. FAU - Yang, Jin-Rong AU - Yang JR AD - Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, 300070, China. FAU - Liu, Zhao-Sheng AU - Liu ZS AD - Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, 300070, China. zhaoshengliu@sohu.com. FAU - Huang, Yan-Ping AU - Huang YP AD - Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, 300070, China. huangyp100@163.com. LA - eng GR - 21775109/National Natural Science Foundation of China/International PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200701 PL - Austria TA - Mikrochim Acta JT - Mikrochimica acta JID - 7808782 SB - IM OTO - NOTNLM OT - Deep eutectic solvents OT - Environmental pollutantant OT - Room temperature ionic liquids OT - Wastewater EDAT- 2020/07/03 06:00 MHDA- 2020/07/03 06:01 CRDT- 2020/07/03 06:00 PHST- 2020/01/31 00:00 [received] PHST- 2020/06/17 00:00 [accepted] PHST- 2020/07/03 06:00 [entrez] PHST- 2020/07/03 06:00 [pubmed] PHST- 2020/07/03 06:01 [medline] AID - 10.1007/s00604-020-04401-9 [pii] AID - 10.1007/s00604-020-04401-9 [doi] PST - epublish SO - Mikrochim Acta. 2020 Jul 1;187(7):418. doi: 10.1007/s00604-020-04401-9.